Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6 - Wikidata - wikimedia - TriplyDB

Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6

Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6

http://www.wikidata.org/entity/Q35024289

about

Biology of adeno-associated viral vectors in the central nervous system A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells Adeno-associated Virus as a Mammalian DNA Vector Parvovirus glycan interactions Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector The structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasion Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6 Structure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)Structural Insights into Adeno-Associated Virus Serotype 5 Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96 Barriers to inhaled gene therapy of obstructive lung diseases: A review Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.Gene therapy in the cornea: 2005--present.Comparative analysis of adeno-associated virus capsid stability and dynamics Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors DNA shuffling of adeno-associated virus yields functionally diverse viral progeny Longitudinal monitoring of Gaussia and Nano luciferase activities to concurrently assess ER calcium homeostasis and ER stress in vivo Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector Recombinant adeno-associated virus: efficient transduction of the rat VMH and clearance from blood.Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport.AAV serotype influences gene transfer in corneal stroma in vivo.Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3 Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo.Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.AAV9 targets cone photoreceptors in the nonhuman primate retina.Recombinant adeno-associated virus serotype 6 efficiently transduces primary human melanocytes Terminal N-linked galactose is the primary receptor for adeno-associated virus 9.High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung.Identification and mutagenesis of the adeno-associated virus 5 sialic acid binding region.Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4 The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction.

P2860

Q21129328-9A634906-F549-446F-9699-B5DAC60BF8BF Q21142728-661FE06B-D077-48B0-9F5F-B665BA621320 Q26782605-FAC156BA-02DE-4CA3-8860-0DFA22507950 Q26858992-C83E32B8-3A5D-4851-BCAE-719CC8E25ECF Q27324340-90D288C9-431A-4F40-8229-DB88FC5D2928 Q27647639-D5EF509E-B725-472F-A324-EC9CB63E52B6 Q27661320-E4B850A8-BE33-43D5-AE3B-289FC6D428A0 Q27664641-BCD244D9-50B3-4574-A5F6-94172591A866 Q27673885-D3958413-812F-4AFB-9252-CC0107BCEC83 Q27679454-AFAF55E3-A50D-4A87-B74F-1CBB2C43D34C Q28296663-247D5E35-2D81-4B7D-AE3F-DD4F2936A259 Q28748622-CD0C3B6F-91D2-49E0-AF69-CF5B1198DD1F Q29248141-76CD359D-59F8-4B8F-B571-986DA7677A5D Q30417445-093DFEF8-7A6B-4F08-9916-28E2167905F6 Q30459643-7F008B42-0F2D-4B11-BF05-767C2039B66F Q30557598-9C9F768D-6D3C-44AB-BE05-461F5A804795 Q30650955-2030A02D-C111-4F06-A439-C39E08171124 Q33363531-5C8BBE90-9B34-4ED9-B4A3-E1EF76739A79 Q33558795-25F940F7-085F-4DE1-ADE5-CCD4736B81DB Q33622746-167DD9DD-E967-4A3C-ACF0-BCD1B1E680F7 Q33624247-D606D1C5-5217-41A6-96D4-2A74A589733D Q33631705-F3102390-13B4-4224-9580-B7937951441C Q33654870-1A1BC4E1-3C54-4AAD-BCD5-CAAA420D712B Q33731154-A0A23C47-42B9-4416-A911-F788EDFEE0F6 Q33930092-3AEA11D3-F513-4912-BFDF-0DCF55D6A31F Q33987448-AEBB2CD1-3318-4A45-8DE3-5C2B47DD6BF9 Q34063628-EDE7843F-A309-4F74-A5C0-9C11BE97B330 Q34079531-657C08FA-EBBD-4900-B14E-77E669B11F3D Q34393166-6E7FBD49-6494-4CF6-8676-BCC7A465301B Q34440312-DA995F8C-2732-475B-9AB3-C554C9D9D768 Q34566454-AFA3B3F6-0E96-45FE-8377-9AF0AF0B42A8 Q34575221-B1103BEB-7414-47B9-9114-EAB9D82E5969 Q34706818-EA5CBDAF-86FC-4B88-847D-E223F14FD2E6 Q34787342-2D594C03-4B89-43B0-AECB-D63885FE1A74 Q34845196-30F65613-FFEE-4DA1-BAB5-A6521E905D30 Q34991472-96C9A795-076B-4864-8052-CED539CA0EBA Q34997974-7CA7FB86-010F-44ED-B779-4EE8ED8A2648 Q35015807-7437BFA8-2E37-4676-9ECE-0697FFA1E59D Q35027496-49718B54-32F2-4F0C-820B-96B070A108D5 Q35086706-9E9997C8-B8C1-4ADE-B32A-038D7464E51D

P2860

Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6

http://www.wikidata.org/entity/Q35024289

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@ast

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@en

type

label

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@ast

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@en

prefLabel

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@ast

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@en

P1433

Q35024289-19771CA1-E2B5-4A82-B65F-4F5A56FD38B9

P1476

Q35024289-AA210A55-2832-400F-9A37-80AF14BCE23A

P2093

Q35024289-166B80BA-3135-400E-BACC-8FA38A823B0D

Q35024289-373E413A-8CBC-4866-BD8E-33FA16E59B07

Q35024289-BC4AD505-0526-48FD-8CB7-D963F1348CDC

P2860

Q35024289-048BCABA-FD54-4261-896E-6C174ACE5089

Q35024289-1384B185-FDC2-41D6-8BE3-C4ECB512D4FC

Q35024289-169F6081-FFA0-4D81-86F4-67E94695F182

Q35024289-1AF5910C-830E-43FA-A0D7-2DAF9C3507EA

Q35024289-21CB5949-DF62-4147-B43B-F90655382BA9

Q35024289-32F0248A-263C-466B-A80E-6A7DB7DE586A

Q35024289-354FB38B-5DFE-406D-9086-12392706E1AA

Q35024289-3FA28575-3D23-4B3A-AADC-3CA6E3FA16E4

Q35024289-4000C4F3-67E8-4455-A052-EA48E51E8EDB

Q35024289-410DE1C3-E6AC-4E2A-A1F7-F22A6ECB5B2B

P304

Q35024289-200EC61C-7443-4968-81A2-0066609322BC

P31

Q35024289-D6A6DAD9-D6B6-43F8-A1F7-1AB42211922E

P356

Q35024289-F0958DED-D1FB-4385-BF43-9E10595FE2FC

P407

Q35024289-B28621E4-8617-4255-A3E4-302FB9211A42

P433

Q35024289-7803F891-0B98-4F8B-9730-5E841796D4AD

P478

Q35024289-59A74A5F-6DE5-469F-83AB-7D6F11D6CD60

P50

Q35024289-EB1ACAB2-BA92-43B5-B55E-DD12EB2D0DC1

P577

Q35024289-87703266-3303-4E6D-BAC0-81B16E663E71

P698

Q35024289-FF43E95B-EA61-4AE3-9E65-DBB15EEC3043

P932

Q35024289-82B29FA0-E257-4092-8A03-59BFDA0A7421

P356

P1433

Journal of Virology

P1476

Alpha2,3 and alpha2,6 N-linked ...... associated virus types 1 and 6

@en

P2093

Edward Miller

http://www.w3.org/2001/XMLSchema#string

Richard Jude Samulski

http://www.w3.org/2001/XMLSchema#string

Zhijian Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

Human and avian influenza viruses target different cell types in cultures of human airway epithelium.

Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis: data on the evolution of the signaling system.

P304

9093-9103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00895-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Mavis Agbandje-McKenna

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16940521

http://www.w3.org/2001/XMLSchema#string

P932

1563919

http://www.w3.org/2001/XMLSchema#string